Read + Share
Amedeo Smart
Independent Medical Education
Testa E, Dezi C, Lovat F, Piro G, et al. Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 2026;123:e2601788123.PMID: 42054368
Email
LinkedIn
Privacy Policy